10-Q Filing

INTUITIVE SURGICAL INC CIK: 1035267 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0001035267-23-000159`
Period End Date	20230630
Filing Date	20230724
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	isrg-20230630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 100 Cash Flow Statement 70

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.44B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.58B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.36B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.54B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$942.10M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$904.20M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$1.01B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$893.20M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	350.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	351.30M	shares	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$299.80M	USD	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$323.20M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	350.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$6.25B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.03B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	351.30M	shares	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$2.83B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$2.37B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$2.62B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$1.33B	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$664.60M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$666.50M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$693.10M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$710.10M	USD	Point-in-time
Goodwill	`Goodwill`	$348.60M	USD	Point-in-time
Goodwill	`Goodwill`	$348.50M	USD	Point-in-time
Total assets	`Assets`	$13.90B	USD	Point-in-time
Total assets	`Assets`	$12.97B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$147.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$199.70M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$346.60M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$401.60M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$405.20M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$397.30M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$586.90M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$476.20M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.42B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.54B	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$405.20M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$439.30M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.94B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.86B	USD	Point-in-time
Contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of June 30, 2023, and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of June 30, 2023, and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Common stock, 600.0 shares authorized, $0.001 par value, 351.3 shares and 350.0 shares issued and outstanding as of June 30, 2023, and December 31, 2022, respectively	`CommonStockValue`	$400.00K	USD	Point-in-time
Common stock, 600.0 shares authorized, $0.001 par value, 351.3 shares and 350.0 shares issued and outstanding as of June 30, 2023, and December 31, 2022, respectively	`CommonStockValue`	$400.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$8.15B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$7.70B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.50B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.81B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-79.80M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-108.50M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-162.50M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-144.20M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-24.20M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-110.70M	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$11.88B	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$11.04B	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$70.70M	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$80.60M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.96B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.11B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.16B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.95B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.08B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.29B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$12.97B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$13.90B	USD	Point-in-time

Income Statement 100 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.01B	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.76B	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.45B	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.52B	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$976.80M	USD	2 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$584.00M	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$1.17B	USD	2 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$498.80M	USD	1 Quarter
Gross profit	`GrossProfit`	$2.03B	USD	2 Qtrs
Gross profit	`GrossProfit`	$1.02B	USD	1 Quarter
Gross profit	`GrossProfit`	$2.28B	USD	2 Qtrs
Gross profit	`GrossProfit`	$1.17B	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$418.40M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$944.80M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$809.50M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$464.30M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$244.40M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$489.30M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$417.80M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$207.30M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$708.70M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$625.70M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.23B	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.43B	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$397.60M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$463.20M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$850.80M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$805.70M	USD	2 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$9.30M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$36.00M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$70.20M	USD	2 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$3.60M	USD	2 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$809.30M	USD	2 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$406.90M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$499.20M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$921.00M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$134.20M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$126.30M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$93.30M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$73.20M	USD	1 Quarter
Net income	`ProfitLoss`	$786.80M	USD	2 Qtrs
Net income	`ProfitLoss`	$313.60M	USD	1 Quarter
Net income	`ProfitLoss`	$426.00M	USD	1 Quarter
Net income	`ProfitLoss`	$683.00M	USD	2 Qtrs
Less: net income attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.20M	USD	1 Quarter
Less: net income attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.80M	USD	1 Quarter
Less: net income attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$10.70M	USD	2 Qtrs
Less: net income attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$9.60M	USD	2 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$776.10M	USD	2 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$307.80M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$420.80M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$673.40M	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.21	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.20	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.86	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.88	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.85	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.84	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.18	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.18	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	350.60M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	350.90M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	358.20M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	358.10M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	365.30M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	357.30M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	356.60M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	363.90M	shares	1 Quarter
Unrealized gains on hedge instruments	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.00M	USD	1 Quarter
Unrealized gains on hedge instruments	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$4.40M	USD	1 Quarter
Unrealized gains on hedge instruments	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$5.40M	USD	2 Qtrs
Unrealized gains on hedge instruments	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$8.50M	USD	2 Qtrs
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$50.70M	USD	2 Qtrs
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-33.40M	USD	1 Quarter
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$13.10M	USD	1 Quarter
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-124.10M	USD	2 Qtrs
Foreign currency translation gains (losses)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$8.50M	USD	1 Quarter
Foreign currency translation gains (losses)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$22.70M	USD	2 Qtrs
Foreign currency translation gains (losses)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00M	USD	2 Qtrs
Foreign currency translation gains (losses)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-5.50M	USD	1 Quarter
Prior service cost for employee benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	1 Quarter
Prior service cost for employee benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	1 Quarter
Prior service cost for employee benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-100.00K	USD	2 Qtrs
Prior service cost for employee benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-34.50M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-120.60M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$81.90M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$27.60M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$868.70M	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$562.40M	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$453.60M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$279.10M	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$4.80M	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$9.00M	USD	2 Qtrs
Less: comprehensive income attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$9.90M	USD	2 Qtrs
Less: comprehensive income attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$4.10M	USD	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$553.40M	USD	2 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$274.30M	USD	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$858.80M	USD	2 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$449.50M	USD	1 Quarter

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$786.80M	USD	2 Qtrs
Net income	`ProfitLoss`	$313.60M	USD	1 Quarter
Net income	`ProfitLoss`	$426.00M	USD	1 Quarter
Net income	`ProfitLoss`	$683.00M	USD	2 Qtrs
Depreciation and loss on disposal of property, plant, and equipment	`DepreciationandGainLossonDispositionofPropertyPlantEquipment`	$157.50M	USD	2 Qtrs
Depreciation and loss on disposal of property, plant, and equipment	`DepreciationandGainLossonDispositionofPropertyPlantEquipment`	$180.00M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$10.00M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$6.20M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$5.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$12.30M	USD	2 Qtrs
Gain on sale of business	`GainLossOnSaleOfBusiness`	-	USD	2 Qtrs
Gain on sale of business	`GainLossOnSaleOfBusiness`	$3.80M	USD	2 Qtrs
Loss on investments, accretion of discounts, and amortization of premiums on investments, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-14.40M	USD	2 Qtrs
Loss on investments, accretion of discounts, and amortization of premiums on investments, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-33.80M	USD	2 Qtrs
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$17.70M	USD	2 Qtrs
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$40.10M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$286.30M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$247.50M	USD	2 Qtrs
Amortization of contract acquisition assets	`CapitalizedContractCostAmortization`	$13.60M	USD	2 Qtrs
Amortization of contract acquisition assets	`CapitalizedContractCostAmortization`	$14.90M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-39.30M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$56.00M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$245.50M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$288.60M	USD	2 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$90.10M	USD	2 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$13.80M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$36.50M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$12.40M	USD	2 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-55.00M	USD	2 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-71.50M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$12.20M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-3.10M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$31.80M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$19.70M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.04B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$669.70M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$14.00M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$1.38B	USD	2 Qtrs
Proceeds from sales of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	-	USD	2 Qtrs
Proceeds from sales of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$37.50M	USD	2 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$1.87B	USD	2 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$1.49B	USD	2 Qtrs
Purchase of property, plant, and equipment	`PaymentsToAcquireProductiveAssets`	$372.40M	USD	2 Qtrs
Purchase of property, plant, and equipment	`PaymentsToAcquireProductiveAssets`	$224.10M	USD	2 Qtrs
Acquisition of businesses, net of cash, and intellectual property and other investing activities	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$7.30M	USD	2 Qtrs
Acquisition of businesses, net of cash, and intellectual property and other investing activities	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$13.30M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$251.50M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.13B	USD	2 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$174.80M	USD	2 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$106.60M	USD	2 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$179.00M	USD	2 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$140.60M	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$350.00M	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$606.60M	USD	2 Qtrs
Payment of deferred purchase consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$3.00M	USD	2 Qtrs
Payment of deferred purchase consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$2.10M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-317.90M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-682.00M	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.00M	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.00M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.86B	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$245.20M	USD	2 Qtrs
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.31B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.55B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.60B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.46B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.31B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.55B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.60B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.46B	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.